We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.1B
AUM Growth
-$1.95B
Cap. Flow
-$2.01B
Cap. Flow %
-182.11%
Top 10 Hldgs %
55.43%
Holding
359
New
34
Increased
188
Reduced
93
Closed
36

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.32B
2
JD icon
JD.com
JD
+$301M
3
BIDU icon
Baidu
BIDU
+$279M
4
NTES icon
NetEase
NTES
+$202M
5
TCOM icon
Trip.com Group
TCOM
+$77.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.58%
2 Technology 17.59%
3 Communication Services 16.9%
4 Healthcare 11.23%
5 Real Estate 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
276
Revolution Medicines
RVMD
$40.2B
$230K 0.02%
+11,805
New +$230K
LOW icon
277
Lowe's Companies
LOW
$116B
$229K 0.02%
1,313
-38
-3% -$7.33K
MYGN icon
278
Myriad Genetics
MYGN
$530M
$227K 0.02%
+12,481
New +$259K
CDW icon
279
CDW
CDW
$17.1B
$224K 0.02%
1,420
-21
-1% -$3.53K
SYK icon
280
Stryker
SYK
$127B
$224K 0.02%
1,124
+35
+3% +$8.22K
CERE
281
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$224K 0.02%
+8,484
New +$241K
ANET icon
282
Arista Networks
ANET
$219B
$222K 0.02%
9,468
+32
+0.3% +$878
HUM icon
283
Humana
HUM
$46.7B
$222K 0.02%
474
-30
-6% -$13.3K
RGNX icon
284
Regenxbio
RGNX
$623M
$221K 0.02%
+8,967
New +$224K
AGEN
285
Agenus
AGEN
$249M
$219K 0.02%
5,749
+2,765
+93% +$100K
EW icon
286
Edwards Lifesciences
EW
$47.6B
$218K 0.02%
2,297
+39
+2% +$4.04K
XNCR icon
287
Xencor
XNCR
$1.44B
$217K 0.02%
+7,917
New +$195K
ARCT icon
288
Arcturus Therapeutics
ARCT
$157M
$216K 0.02%
13,735
+1,825
+15% +$35.8K
CEG icon
289
Constellation Energy
CEG
$98B
$216K 0.02%
3,765
+43
+1% +$2.59K
RCL icon
290
Royal Caribbean
RCL
$78.7B
$216K 0.02%
6,175
+2,787
+82% +$173K
VXRT
291
DELISTED
Vaxart
VXRT
$216K 0.02%
61,614
+11,625
+23% +$43.4K
CDMO
292
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$214K 0.02%
13,994
+3,159
+29% +$46.7K
MS icon
293
Morgan Stanley
MS
$337B
$211K 0.02%
2,779
-21
-0.8% -$1.72K
IT icon
294
Gartner
IT
$9.41B
$206K 0.02%
850
-25
-3% -$6.65K
BSX icon
295
Boston Scientific
BSX
$65.8B
$205K 0.02%
5,493
+134
+3% +$5.46K
CNC icon
296
Centene
CNC
$31.3B
$203K 0.02%
2,401
-27
-1% -$2.24K
GS icon
297
Goldman Sachs
GS
$313B
$203K 0.02%
682
+19
+3% +$5.92K
LMT icon
298
Lockheed Martin
LMT
$134B
$203K 0.02%
471
-8
-2% -$3.51K
ZS icon
299
Zscaler
ZS
$23B
$201K 0.02%
1,347
+31
+2% +$5.48K
MORF
300
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$201K 0.02%
+9,266
New +$259K

Similar funds

E Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, E Fund Management held 359 positions worth $1.1B, down 64% from $3.06B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

E Fund Management withdrew a net $2.01B in Q2 2022, closing 36 positions and reducing 93 holdings. Its most notable exit was Alibaba, an estimated $1.32B position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Sea Limited worth $22.9M.

  • E Fund Management's largest Q2 2022 buy was Sea Limited: 342,000 shares worth $22.9M.
  • E Fund Management added most to STAAR Surgical in Q2 2022, an estimated $38.7M increase.
  • E Fund Management's biggest Q2 2022 reduction was JD.com, cutting an estimated $301M.
  • E Fund Management fully exited Alibaba in Q2 2022, selling an estimated $1.32B.
  • E Fund Management's ten largest holdings make up 55% of its $1.1B portfolio in Q2 2022.
  • E Fund Management opened 34 new positions and closed 36 in Q2 2022.
  • E Fund Management's portfolio value fell 64% quarter-over-quarter to $1.1B.

Based on E Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.